1. Home
  2. BIO vs GMED Comparison

BIO vs GMED Comparison

Compare BIO & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$301.38

Market Cap

8.2B

Sector

Industrials

ML Signal

N/A

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

N/A

Current Price

$85.28

Market Cap

11.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
GMED
Founded
1952
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
11.3B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
BIO
GMED
Price
$301.38
$85.28
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$358.50
$93.09
AVG Volume (30 Days)
163.5K
1.6M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
358.86
EPS
N/A
3.08
Revenue
$2,557,500,000.00
$2,769,804,000.00
Revenue This Year
$1.77
$16.66
Revenue Next Year
$2.30
$8.27
P/E Ratio
N/A
$27.86
Revenue Growth
N/A
11.75
52 Week Low
$211.43
$51.79
52 Week High
$373.69
$94.93

Technical Indicators

Market Signals
Indicator
BIO
GMED
Relative Strength Index (RSI) 40.11 53.12
Support Level $298.02 $87.72
Resistance Level $319.50 $87.34
Average True Range (ATR) 8.25 1.95
MACD -2.09 -1.38
Stochastic Oscillator 11.61 5.90

Price Performance

Historical Comparison
BIO
GMED

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: